Audentes Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$137.5M
Lead Investor(s):BofA Merrill Lynch, J.P. Morgan Securities LLC

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Audentes Therapeutics's estimated annual revenue is currently $26.7M per year.(?)
  • Audentes Therapeutics received $172.5M in venture funding in October 2018.
  • Audentes Therapeutics's estimated revenue per employee is $73,850
  • Audentes Therapeutics's total funding is $137.5M.

Employee Data

  • Audentes Therapeutics has 361 Employees.(?)
  • Audentes Therapeutics grew their employee count by 22% last year.
  • Audentes Therapeutics currently has 36 job openings.

Audentes is a biotechnology company committed to the development and commercialization of innovative new medicines for people with serious, rare muscle diseases. We are a passionate, energetic team driven by the goals of improving the lives of patients and building a successful business. We take pride in strong, global relationships with the patient, research, and medical communities. If you are interested in learning more about our company, please do not hesitate to contact us.